Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours Β· Estimated delivery Sep 4 - Sep 9
Foviscu (WCK 4282) - Phase 3 Ongoing First-line empiric treatment for gram-negative hospital infections (cUTI, HABP/VABP) Complements ZAYNICH: while ZAYNICH is the destination therapy at the top of the pyramid for resistant infections, Foviscu is the entry-level, broad-use first drug of choice Global Phase 3 trial underway If approved, the commercial TAM is significantly larger than ZAYNICH due to broader use 5
It helps protect cartilages of the joint and encourages regeneration, thus preventing arthritis
It contains a combination of ingredients like L-glutathione, Alpha Lipoic Acid, Vitamin C, and Biotin, all of which support healthy skin and overall detoxification
Cathepsin L CTSB activates trypsinogen, whereas cathepsin L (CTSL) inactivates it
When you add these foods to your meals, you help your body defend itself and stay well
US$ 25.55
US$ 29.51
,aspect=fit)
US$ 28.90
US$ 22.70
